secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2022-06-30T23:59:59+00:00
Accession:  0001193125-22-186327
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed enters amended $1.5B revolver and $200M term loan, both maturing June 2027
--------------------------------------------------------------------------------

- Revolver reduced from $1.6B to $1.5B; includes uncommitted $1B increase option.
- New $200M term loan from ResMed Pty subsidiary; amortizes $5M semi-annually.
- Both facilities mature June 29, 2027; interest at SOFR+0.75%-1.50% or Base Rate+0.0%-0.50%.
- Proceeds for general corporate purposes; financial covenant maintains max leverage ratio.
- Obligations guaranteed by specified U.S. subsidiaries including Brightree and MatrixCare.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312522186327/0001193125-22-186327-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312522186327/d363805d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-186327

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer